Cellebrite DI (CLBT) Shares Outstanding (Weighted Average) (2020 - 2025)

Cellebrite DI (CLBT) has reported Shares Outstanding (Weighted Average) for 6 consecutive years, with $245.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 5.16% year-over-year to $245.3 million; the TTM figure through Dec 2025 stood at $245.3 million (up 5.16% YoY), while the FY2025 annual figure was $245.3 million, up 5.16% from the prior year.
• Shares Outstanding (Weighted Average) came in at $245.3 million for Q4 2025 at Cellebrite DI, up from $6.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $245.3 million in Q4 2025, with the low at $6.0 million in Q2 2025.
• Average Shares Outstanding (Weighted Average) over 5 years is $174.6 million, with a median of $183.3 million recorded in 2022.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 45.56% in 2021 and tumbled 96.97% in 2025, its largest moves.
• Year by year, Shares Outstanding (Weighted Average) stood at $180.2 million in 2021, then rose by 1.72% to $183.3 million in 2022, then gained by 2.65% to $188.1 million in 2023, then climbed by 23.98% to $233.2 million in 2024, then climbed by 5.16% to $245.3 million in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $245.3 million, $6.0 million, and $237.2 million for Q4 2025, Q2 2025, and Q1 2025 respectively.